12/22
09:30 am
tsha
Is FDA Breakthrough Status For TSHA-102 Reshaping The Investment Case For Taysha Gene Therapies (TSHA)? [Yahoo! Finance]
Medium
Report
Is FDA Breakthrough Status For TSHA-102 Reshaping The Investment Case For Taysha Gene Therapies (TSHA)? [Yahoo! Finance]
12/22
08:36 am
tsha
Taysha Gene Therapies (TSHA): Revisiting Valuation After Breakthrough Rett Data and Bullish Analyst Upgrades [Yahoo! Finance]
Medium
Report
Taysha Gene Therapies (TSHA): Revisiting Valuation After Breakthrough Rett Data and Bullish Analyst Upgrades [Yahoo! Finance]
12/21
07:42 am
tsha
Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program [Yahoo! Finance]
Medium
Report
Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program [Yahoo! Finance]
12/13
01:10 am
tsha
Taysha Gene Therapies (NASDAQ:TSHA) was upgraded by analysts at
Wall Str
Low
Report
Taysha Gene Therapies (NASDAQ:TSHA) was upgraded by analysts at
Wall Str
12/5
04:05 pm
tsha
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12/4
08:10 am
tsha
Taysha Gene Therapies (NASDAQ:TSHA) was given a new $11.00 price target on by analysts at UBS Group AG.
Medium
Report
Taysha Gene Therapies (NASDAQ:TSHA) was given a new $11.00 price target on by analysts at UBS Group AG.
12/4
07:04 am
tsha
Taysha Gene Therapies (NASDAQ:TSHA) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "buy" rating.
Medium
Report
Taysha Gene Therapies (NASDAQ:TSHA) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "buy" rating.
12/4
07:03 am
tsha
Taysha Gene Therapies (NASDAQ:TSHA) was given a new $11.00 price target on by analysts at The Goldman Sachs Group, Inc..
Medium
Report
Taysha Gene Therapies (NASDAQ:TSHA) was given a new $11.00 price target on by analysts at The Goldman Sachs Group, Inc..
11/4/2025
07:00 am
TSHA
taysha gene therapies, inc.
IN-LINE
Report
-1.8%
taysha gene therapies, inc.
8/12/2025
08:01 am
TSHA
taysha gene therapies, inc.
MISS
Report
-3.2%
taysha gene therapies, inc.
5/15/2025
08:00 am
TSHA
taysha gene therapies, inc.
IN-LINE
Report
5.8%
taysha gene therapies, inc.
Raymond James Financial, Inc.
12/1
08:59 pm
tsha
Form 4 Taysha Gene Therapies, For: Nov 28 Filed by: Nagendran Sukumar
Medium
Report
Form 4 Taysha Gene Therapies, For: Nov 28 Filed by: Nagendran Sukumar
11/28
01:07 pm
tsha
Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
Neutral
Report
Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
11/14
04:52 pm
tsha
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: Octagon Capital Advisors LP
11/14
04:25 pm
tsha
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
11/4
08:30 am
tsha
Form S-3ASR Taysha Gene Therapies,
Low
Report
Form S-3ASR Taysha Gene Therapies,
11/4
07:12 am
tsha
Form 8-K Taysha Gene Therapies, For: Nov 04
Low
Report
Form 8-K Taysha Gene Therapies, For: Nov 04
11/4
06:55 am
tsha
Form 10-Q Taysha Gene Therapies, For: Sep 30
Low
Report
Form 10-Q Taysha Gene Therapies, For: Sep 30
10/16
04:10 pm
tsha
Form 8-K Taysha Gene Therapies, For: Oct 16
Medium
Report
Form 8-K Taysha Gene Therapies, For: Oct 16
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register